Min Y

ORCID: 0000-0003-4606-5785 · 1 paper in corpus
2023
Genes ·doi:10.3390/genes14040886

In ovarian cancer patients, the 5-year survival rate is 90% for stages I and II, but only 30% for stages III and IV. Unfortunately, as 75% of the patients are diagnosed at stages III and IV, many experience a recurrence. To ameliorate this,…